114 related articles for article (PubMed ID: 8996452)
1. Toxoid vaccine for pertussis.
Preston NW; Matthews RC
Lancet; 1997 Jan; 349(9045):137; author reply 137-8. PubMed ID: 8996452
[No Abstract] [Full Text] [Related]
2. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned.
Schneerson R; Robbins JB; Taranger J; Lagergård T; Trollfors B
Lancet; 1996 Nov; 348(9037):1289-92. PubMed ID: 8909384
[No Abstract] [Full Text] [Related]
3. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
[No Abstract] [Full Text] [Related]
4. Toxoid vaccine for pertussis.
von König CH; Schmitt HJ
Lancet; 1997 Jan; 349(9045):136; author reply 137-8. PubMed ID: 8996450
[No Abstract] [Full Text] [Related]
5. A placebo-controlled trial of a pertussis-toxoid vaccine.
Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
[TBL] [Abstract][Full Text] [Related]
6. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of the pertussis component in the triple vaccine].
Schümann C; Heinrich H
Dtsch Gesundheitsw; 1971 Feb; 26(7):323-7. PubMed ID: 5110218
[No Abstract] [Full Text] [Related]
8. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
N Y State J Med; 1982 Oct; 82(11):1563-9. PubMed ID: 6959004
[No Abstract] [Full Text] [Related]
9. Why quantity of diphtheria and pertussis vaccines is reduced for children 7 years onwards?
Paul Y
Indian Pediatr; 2012 Feb; 49(2):160; author reply 160. PubMed ID: 22410526
[No Abstract] [Full Text] [Related]
10. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus.
Adam E; Burian V; Kubátová E; Kratochvílovă M; Buriánov'A B; Kyselová M; Demelová M; Hejdová E
J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):88-101. PubMed ID: 5462049
[No Abstract] [Full Text] [Related]
11. Similarities between the pathogenesis of and immunity to diphtheria and pertussis: the complex nature of serum antitoxin-induced immunity to these two diseases.
Schneerson R
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S136-9. PubMed ID: 10447032
[TBL] [Abstract][Full Text] [Related]
12. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
[TBL] [Abstract][Full Text] [Related]
13. Neurologic manifestations of diphtheria and pertussis.
Sanghi V
Handb Clin Neurol; 2014; 121():1355-9. PubMed ID: 24365424
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and immunological indices in children immunized with DPT vaccine on a disrupted schedule].
Aleksina SG; Veĭsfeĭler OIu; Podshivalova VA; Kovalskaga SYa ; Braginskaia VP
Vopr Okhr Materin Det; 1974 Sep; 19(9):47-50. PubMed ID: 4422421
[No Abstract] [Full Text] [Related]
15. Immunization against diphtheria, pertussis and tetanus.
Rubio T
J Okla State Med Assoc; 1969 Mar; 62(3):100-2. PubMed ID: 5774602
[No Abstract] [Full Text] [Related]
16. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Jul; 34(27):405-14, 419-26. PubMed ID: 3925316
[No Abstract] [Full Text] [Related]
17. Experiences with a new combined vaccine against B. parapertussis, Diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10.
Burianová-Vysoká B; Burian V; Kríz B; Pellar T; Hellerová J; Rádkovský J
Prog Immunobiol Stand; 1967; 3():335-40. PubMed ID: 4314432
[No Abstract] [Full Text] [Related]
18. New combined alum hydroxide adsorbed diphtheria-tetanus-pertussis-vaccine with parapertussis component. I. Reactogenicity and serological efficacy.
Burián V; Kubátová E; Kratochvílová M; Buriánová-Vysoká B
J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):143-7. PubMed ID: 5463707
[No Abstract] [Full Text] [Related]
19. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
Heininger U; Stehr K; Christenson P; Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
[TBL] [Abstract][Full Text] [Related]
20. [Timing of the 2d diphtheria-pertussis-tetanus vaccination with special reference to the prevention of pertussis].
Erdös L; Solt K; Kiss I
Orv Hetil; 1971 Jun; 112(26):1515-7. PubMed ID: 5114730
[No Abstract] [Full Text] [Related]
[Next] [New Search]